| 1 |
Partly verified |
Full text not readStored summary read |
N01 · Evidence conditionWhich existing all-app claim is being transferred?Required |
The selected claim concerns recurrence prevention by any app-based ankle exercise. Its original subclaim grade is D; the note concerns the null 2023 trial with a different delivery method. Missing subclaim scores/status/axes are distinguished from the parent balance-board score of B with 76 points. There is no reassessment that every app has exactly zero effect. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
The broad wording, subclaim grade and parent B grade |
Materials needed: Definitions of the app/training/population/comparator, recurrence endpoint and duration, plus review of the claim boundary. Parent scores/effects are not transferred to the subclaim. Only requests/material needs are recorded; no search or research is performed in this work. |
| 2 |
Unverified |
Full text not readStored summary read |
N02 · Evidence conditionDoes direct evidence cover every app?Required |
The original advertising interpretation explains that this does not mean every ankle-exercise app prevents recurrence: the result is limited to the eight-week program providing a balance board, sheets, DVD and web materials. Direct evidence accounting for differences in all apps/programs, their content, exposure and support remains unverified. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Applicability of delivery, content and support |
Materials needed: App identity/version, content/support, actual exposure, population/comparator/endpoint and direct comparisons/applicability. No app/device recommendations or training instructions. Only requests/material needs are recorded; no search or research is performed in this work. |
| 3 |
Partly verified |
Full text not readStored summary read |
N03 · Evidence conditionWas 2BFit a trial of an app alone?Required |
2BFit used eight weeks of home neuromuscular training with a balance board, sheets, DVD and web materials after usual care. Including web materials does not newly define the trial as testing an app alone, every app or the board alone. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
The specific combined delivery program and its components |
Materials needed: Components/exposure, support/contact, adherence and direct comparisons with apps/other delivery methods. No certification separating the effects of individual components in the combined program. Only requests/material needs are recorded; no search or research is performed in this work. |
| 4 |
Partly verified |
Full text not readStored summary read |
N04 · Evidence conditionHow much is known about the population and identity of the 2023 app trial?Required |
The original counterview records a 2023 primary-care app trial in 165 people. Formal bibliography/registration, app name/version, previous sprains/age, eligibility, actual intervention/comparator and duration are not detailed. The 2BFit information on 522 athletes aged 12 to 70 is not copied to the app trial. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Primary-care trial in 165 people and an unidentified report |
Materials needed: Exact paper/registration, app/population/intervention/comparator/duration and endpoint/denominator materials. Unread external materials or unidentified bibliography are not changed into absence of research. Only requests/material needs are recorded; no search or research is performed in this work. |
| 5 |
Partly verified |
Full text not readStored summary read |
N05 · Evidence conditionAre the app HR and balance-board RR distinguished?Required |
The original app result is described as null, HR 1.14 (0.59 to 2.21). This is a different effect measure and trial from 2BFit's adjusted RR 0.63. It is not newly judged to establish zero effect for every app, equivalence, harm or an identical comparison. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
App HR 1.14 and CI 0.59 to 2.21 |
Materials needed: The app estimand, model/adjustment, follow-up/testing, denominators/event counts and original CI/prespecified threshold. No HR/RR conversion or new effect/CI calculation. Only requests/material needs are recorded; no search or research is performed in this work. |
| 6 |
Partly verified |
Full text not readStored summary read |
N06 · Evidence conditionHave app adherence of 6.1% and balance-board adherence of 23% been certified as comparable?Required |
Original app adherence of 6.1% and 2BFit full adherence of 58/256 (23%) remain in their respective contexts. Differences in adherence definitions, denominators and measurement are unverified; no causal conclusion that low adherence caused the null result or a new adherence difference is created. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Adherence in different programs |
Materials needed: Adherence definitions in both studies, actual exposure, aggregation/missingness, support, direct comparisons and analysis. No new adherer effects, differences or rates. Only requests/material needs are recorded; no search or research is performed in this work. |
| 7 |
Unverified |
Full text not readStored summary read |
N07 · Evidence conditionAre the app's actual comparator and concomitant care known?Required |
The app trial is described only as primary care/another delivery method in the original summary. Comparator identity, concomitant care/contamination and exposure remain unverified. 2BFit's usual-care comparator or the bracing comparison is not automatically used as the app comparator. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
The unverified app comparator and usual-care comparator |
Materials needed: The actual app comparator, concomitant care/training, contact/expectations, contamination and recovery/sports exposure. Different comparisons are not combined. Only requests/material needs are recorded; no search or research is performed in this work. |
| 8 |
Unverified |
Full text not readStored summary read |
N08 · Evidence conditionAre the app recurrence endpoint and prespecified hierarchy verified?Required |
The original app HR is described as null, but details of recurrence definitions, same/other ankle, first/repeated events, confirmation and prespecified endpoints are absent. 2BFit's monthly reporting, independent adjudication and primary-endpoint definition are not copied to the app trial. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Exact app events and primary/secondary plans |
Materials needed: Original app endpoints, registration/SAP, event counting, adjudication/measurement, prespecified hierarchy and all results. Unverified details are not all declared unmeasured. Only requests/material needs are recorded; no search or research is performed in this work. |
| 9 |
Unverified |
Full text not readStored summary read |
N09 · Evidence conditionAre app duration and 2BFit's eight weeks/12 months kept separate?Required |
2BFit used an eight-week program with 12-month follow-up; the original app reference does not provide exact intervention/follow-up duration. Those periods or three sessions weekly/up to 30 minutes are not transferred as app-trial exposure. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Gaps in applying intervention and follow-up time points |
Materials needed: Actual app duration/exposure/adherence, observation/attrition, time-specific results and comparability. No new day counts/total dose or exercise instructions. Only requests/material needs are recorded; no search or research is performed in this work. |
| 10 |
Partly verified |
Full text not readStored summary read |
N10 · Evidence conditionHas the positive balance-board result been transferred to every app?Required |
Original 2BFit results of 56/256 versus 89/266, adjusted RR 0.63 (CI 0.45 to 0.88), NNT 9 and original −11 percentage points are limited to the specific balance-board delivery program. They are not copied as values for the app HR or prevention by every app. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Limits of 2BFit's one-year 22% versus 33%, RR and NNT |
Materials needed: Direct app/board comparisons, population/intervention/comparator, events/duration and effect/CI/denominator materials. No new pooled effects or product/treatment recommendations. Only requests/material needs are recorded; no search or research is performed in this work. |
| 11 |
Unverified |
Full text not readStored summary read |
N11 · Evidence conditionAre 165 app participants kept separate from events and denominators?Required |
The original app count of 165 people is recorded; group allocation/completion/analysis, recurrence events/observation and attrition are not detailed. The board trial's 256/266, 56/89 and 14% attrition are not copied to the app, and new group-specific app numbers are not divided out. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
App participant count and unverified events by group |
Materials needed: The app flow diagram, event/observation/analysis denominators, people/ankles/repetition/exposure time and missing-data materials. No new group denominators or participant totals. Only requests/material needs are recorded; no search or research is performed in this work. |
| 12 |
Unverified |
Full text not readStored summary read |
N12 · Evidence conditionAre the direct effects of delivery separated from content and adherence?Required |
The original materials explain that supplying a balance board/DVD differs from app delivery in primary care. Direct evidence separating which content, support, population/exposure or adherence component produced the difference is absent. Causes or superiority attributable only to app delivery are not newly established. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Comparison gaps between combined support and app delivery |
Materials needed: Direct comparisons matching content/exposure, support/contact/adherence, population/comparator and results/denominators. No app/device selection or exercise instructions. Only requests/material needs are recorded; no search or research is performed in this work. |
| 13 |
Partly verified |
Full text not readStored summary read |
N13 · Evidence conditionHas the 2014 bracing superiority result been transferred to app effects?Required |
The original 2014 reference compares 12-month bracing, described as superior, with eight-week training. Bibliography, population/denominators, exact effects/CI and events/exposure are unverified. This is not substituted for the app comparator, app effect or the effect of all exercise. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Twelve-month bracing versus eight-week training |
Materials needed: The original 2014 report, registration, actual bracing/training, duration/adherence and event/denominator/effect/CI materials. No brace/device recommendations or treatment instructions. Only requests/material needs are recorded; no search or research is performed in this work. |
| 14 |
Unverified |
Full text not readStored summary read |
N14 · Evidence conditionHas no difference in the 2017 review been expressed as equivalence?Required |
The original 2017 review reference says no difference in 12-month recurrence rates was found between training and bracing. Included trials/overlap, effects/CI, heterogeneity and precise formulation/delivery are absent. This is not changed into equivalence, effects of every app or certification of independent trial counts. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Review of 12-month recurrence rates with training/bracing |
Materials needed: Review bibliography/methods, included reports/trials, overlap, direct comparisons/duration and effects/CI. No new pooled effect/CI or unique-trial-count calculation. Only requests/material needs are recorded; no search or research is performed in this work. |
| 15 |
Unverified |
Full text not readStored summary read |
N15 · Evidence conditionHave ascertainment procedures been automatically transferred to the app trial?Required |
2BFit used monthly self-report followed by adjudication by a masked physiotherapist/researcher. App reporting, confirmation and masking are not detailed in the original reference. The shared word recurrence does not certify identical measurement accuracy. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
2BFit self-report/masked adjudication and unverified app procedures |
Materials needed: App event reporting/omissions, independent adjudication, examination/clinical confirmation, masking, expectations and original materials. No formal RoB assessment or grade change. Only requests/material needs are recorded; no search or research is performed in this work. |
| 16 |
Partly verified |
Full text not readStored summary read |
N16 · Evidence conditionHave different trials been newly counted as direct conflict or independent replication?Required |
The original counterview did not count the app trial as direct conflict with 2BFit because delivery differed. That original boundary remains; a single bibliography, unidentified contexts and studies included in a review are not newly certified as independent replications. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Original delivery differences and applicability of comparisons |
Materials needed: Same/different cohorts, population/intervention/comparator/events, independence/overlap and direct comparability for each report. No new reassessment or independence calculation. Only requests/material needs are recorded; no search or research is performed in this work. |
| 17 |
Unverified |
Full text not readStored summary read |
N17 · Evidence conditionHas recurrence prevention by every app been extended to broader populations?Required |
The parent record concerns one-year recurrence in previously injured athletes using a specific program. It is not extended to every app, the general population, another ankle, first injuries or prevention across all periods. The original app population/comparison/time are not detailed. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Applicability gaps by program, population and duration |
Materials needed: Direct population/intervention/comparator, recurrence/first injury, duration and denominator/effect/CI materials for each applicability question. No rehabilitation/prevention/treatment-replacement instructions. Only requests/material needs are recorded; no search or research is performed in this work. |
| 18 |
Partly verified |
Full text not readStored summary read |
N18 · Evidence conditionHas a new method to solve low adherence been created?Supplementary |
Original adherence of 23% and app adherence of 6.1% are reports in their own contexts. This records material gaps without creating a specific app choice, encouragement/exercise method, device/rehabilitation/recurrence-prevention or treatment-replacement plan. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Distinguishing research exposure/delivery gaps from instructions |
Materials needed: Materials explaining actual exposure/support, adherence measurement, deviations/contamination and direct effects. Distinguish subsequent material work after content review from authority to provide practical instructions. Only requests/material needs are recorded; no search or research is performed in this work. |
| 19 |
Unverified |
Full text not readStored summary read |
N19 · Harm-information gaps supplementing the efficacy tableIs the safety of apps or other delivery methods known?Supplementary |
2BFit has gaps in separate collection/reporting of exercise AE tables; app/bracing/review references lack detailed harms. The board trial's reporting limits are not copied as facts from the app report, and harmlessness or harmfulness of every app is not newly asserted. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Study-specific harm collection, exposure and denominators |
Materials needed: Study-specific AE/discontinuation, actual exposure, events/denominators/attribution and long-term/rare-harm materials. No device/app recommendations or exercise/rehabilitation/prevention instructions. Only requests/material needs are recorded; no search or research is performed in this work. |
| 20 |
Partly verified |
Full text not readStored summary read |
N20 · Evidence conditionWhat was actually read/identified?Required |
The complete preserved parent summary was read for production and retained in the original archive. The single citation identifies 2BFit; three app/bracing/review entries are unidentified counterview contexts. All external abstracts/full texts/registration/plans remain unread. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Preserved summary/original citation versus unidentified reference contexts |
Materials needed: Exact report citations/originals, acquisition/reading scope, versions/dates. URLs/historical quotations are not upgraded to current reading; no external-link/access testing. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 21 |
Partly verified |
Full text not readStored summary read |
N21 · Evidence conditionAre registration dates/prespecification treated as current certification?Required |
Original evidence/Korean text describes matching ISRCTN34177180 with the self-reported recurrence primary endpoint. Original study facts say the first registration public date was unestablished, so prospective registration was not asserted. App/bracing/review registrations are unidentified. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
ISRCTN34177180 and unestablished first public date |
Materials needed: Actual registration versions/publication, start/amendment timing and endpoints/plans. No guessed official URLs, new registration reading or prespecification certification. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 22 |
Unverified |
Full text not readStored summary read |
N22 · Evidence conditionWere protocol/SAP and estimand/missingness plans acquired?Required |
Preserve original primary/ITT/allocation/adjudication descriptions and historical cross-checking. Each trial’s protocol/SAP, versions/timing and missingness/multiplicity/analysis plans were not acquired/read now. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Separate prespecified-plan/analysis/amendment materials |
Materials needed: Original protocols/SAP, amendment histories, endpoints/models/people/events/exposure, missingness/sensitivity and public timing. Unread external materials do not establish document absence. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 23 |
Partly verified |
Full text not readStored summary read |
N23 · Evidence conditionAre public funding, board supply and company involvement separated?Required |
2BFit had ZonMw grant 750-20-002, declarations of no financial benefit/competing interests and Avanco AB boards supplied to participants. Preserve the original limitation that manufacturer donation/funding/analysis/writing/publication support was not reported. Supply is not manufacturer donation; employee authors/roles and app/bracing/review funding remain unverified now. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
2BFit support versus unverified other contexts |
Materials needed: Item-specific company funding, product support, employee authors, design/analysis/data control and other support for each study. I2 does not establish absence of every item or independence certification. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 24 |
Partly verified |
Full text not readStored summary read |
N24 · Evidence conditionAre specific positive effects, different-delivery null results and unverified details distinguished?Required |
Positive 2BFit recurrence, null 2023 app HR, 2014 bracing superiority and no difference in the 2017 review concern different contexts. Separate original descriptions from unverified citation/effect/harm details; no new verdict on broad claims. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Question/comparison-specific results and reading status |
Materials needed: Report-specific direct populations/interventions/comparators, endpoints/durations, effects/CI/denominators and actual access. Unread does not mean unreported; null does not mean zero effect/equivalence. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 25 |
Partly verified |
Full text not readStored summary read |
N25 · Evidence conditionAre one original citation and three reference contexts counted as unique trials?Required |
Parent 2975 and its s0/s1 claims share original 2BFit citation/trial context and counterview mentions of the 2023 app, 2014 bracing and 2017 review. The same people, ankles, arms, events, times, citations, related sheets and review-included trials are not newly added as independent trials/participants. Four links comprise one identified paper and three unidentified contexts, including a 2017 review; they are not certification of four unique clinical trials or participant totals. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Document/context items versus trials/participants |
Materials needed: Citations/registration, review-included reports/overlap, cohorts/analysis, endpoints/repetition relationships. Unique trial/participant totals remain unrecorded. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 26 |
Unverified |
Full text not readStored summary read |
N26 · Evidence conditionAre original single confirmation and independent replication distinguished?Supplementary |
Preserve parent replication R1/independence I2 and the original single confirmatory-trial description. App/bracing/review contexts are not counted as new same-condition independent replication/conflicts or unique-trial certification. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Parent R1/I2 and comparison/delivery differences |
Materials needed: Separate prespecified, direct population/delivery/comparator/events, effects/CI/denominators, funding/author relationships and overlap materials for the selected question. No search/independence determination now. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 27 |
Partly verified |
Full text not readStored summary read |
N27 · Evidence conditionAre the subclaim grade and parent score/axes preserved?Required |
The selected subclaim's D grade, note and bilingual question are preserved; absent subclaim scores/status/axes remain unrecorded. Parent B with 76 points, unknown safety, B/H/R1/I2/E+/B0, unrecorded precision and the true big-hard-RCT indicator remain parent context and do not fill subclaim values. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Selected D grade, missing subclaim values and parent B with 76 points |
Materials needed: User subclaim/parent-boundary review and actual correction materials. No new score/grade or official RoB 2/GRADE certification. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 28 |
Partly verified |
Full text not readStored summary read |
N28 · Evidence conditionAre both languages, citations and absent fields preserved?Required |
Preserve original parent bilingual quotations/descriptions, evidence, citations and axes and selected-subclaim values in the complete original archive. Classification fields are absent and no new original fields are filled. No English-paper comparison now. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Both original languages and absent separate classification information |
Materials needed: User review of languages/terminology, event/exposure units, absences and selected scope. Distinguish production descriptions from original values. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 29 |
Partly verified |
Full text not readStored summary read |
N29 · Evidence conditionAre source dates/corrections/history separated from production dates?Required |
Preserve original evidence date 2026-08-26, empty corrections/deliberation and verdict-decision cross-checking. Historical quotations/registration matching differ from current production, condition freezing/application and completed content review. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Original 2026-08-26 and new conditions/application |
Materials needed: Update materials separating originals, events, conditions/observations and verdict decisions when new evidence/corrections arise. Historical wording is not completed clinical content review here. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 30 |
Unverified |
Full text not readStored summary read |
N30 · Evidence conditionWhat direct materials would fill the selected gaps?Supplementary |
The all-app claim requires program-specific direct population/delivery/comparator/event/duration materials and comparability. A positive 2BFit result or one null app result does not create a general conclusion. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Direct population/delivery/events, effects/CI and denominators |
Materials needed: Question-specific tables/plans, direct comparisons/applicability, effects/CI, people/ankle/event/exposure denominators, missingness/adherence, separate confirmation and long-term harms. Need recorded only; no search/research now. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 31 |
Partly verified |
Full text not readStored summary read |
N31 · Evidence conditionAre applicability records separated from content review and instructions?Supplementary |
These are summary-based applicability records. Existing content/question-boundary review remains incomplete; candidate pending/eligible markers are preserved as history. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Applicability records, existing candidate history and content review |
Materials needed: Content review and subsequent actual evidence/correction work. Original content-production scope excludes clinical QA/testing, external-link/access/web/API research, new calculations/grades and device/app recommendations or exercise/rehabilitation/prevention/treatment-replacement instructions. Only material-request/research needs are recorded; no search/research was performed in this production. |